Refsum disease, peroxisomes and phytanic acid oxidation: A review

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 11, 2001, Pages 1021-1031

  Wanders, Ronald J A ^a,c   Jansen, Gerbert A ^a   Skjeldal, Ola H ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Fatty acids; Genetic diseases; Peroxisomes; Refsum disease

Indexed keywords

FATTY ACID; PHYTANIC ACID;

BIOACCUMULATION; CLINICAL FEATURE; ENZYME DEFECT; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENETIC DISORDER; GENETIC HETEROGENEITY; HUMAN; LIPID METABOLISM; MOLECULAR BIOLOGY; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; REFSUM DISEASE; REVIEW;

EID: 0034764947     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.11.1021     Document Type: Review

References (61)

1. Heredopathia atactica polyneuritiformis
2. Ueber das vorkommen der 3,7,11,15-tetramethylhexadecansaure (phytansaure) in den cholesterinestern und anderen lipidfraktionen der organe bei einem krankheitsfall unbekanter genese (Verdacht auf Heredopathia atactica polyneuritiformis, Refsum's syndrome)
3. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation
4. Phytanic acid alpha-oxidase deficiency (Refsum disease) presenting in infancy
5. Refsum disease
6. Refsum disease: The presentation and ophthalmic aspects of Refsum disease in a series of 23 patients
7. Refsum's syndrome
8. An ocular pathologic study of Refsum's syndrome
9. Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease)
10. Heredopathia actactica polyneuritiformis (Refsum's disease)
11. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies
12. Quantitative EMG analysis and longitudinal nerve conduction studies in a Refsum's disease patient
13. Heredopathia atactica polyneuritiformis: Refsum's disease
14. Heredopathia atactica polyneuritiformis (Refsum's diseases). An audiological examination of two patients
15. Heredopathia atactica polyneuritiformis. Phytanic acid storage disease (Refsum disease)
16. Refsum's disease revealed by cardiac disorders
17. Cardiac involvement in neuromuscular diseases
18. Epidermal abnormalities in Refsum's disease
19. Epidermal metabolism in heredopathia atactica polyneuritiformis (Refsum's disease)
20. Refsum's disease (heredopathia atactica polyneuritiformis)
21. The fatty acid composition of skin and plasma lipids in Refsum's disease
22. Di-, mono- and nonphytanyl triglycerides in the serum: A sensitive parameter of the phytanic acid accumulation in Refsum's disease
23. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease
24. The transformation of phytol into 3,7,11,15-tetramethylhexadecanoic (phytanic) acid in heredopathia atactica polyneuritiformis (Refsum's syndrome)
25. Conversion of U-C14-phytol to phytanic acid and its oxidation in heredopathia atactica polyneuritiformis
26. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease
27. A major pathway for the mammalian oxidative degradation of phytanic acid
28. Studies on the alpha oxidation of phytanic acid by rat liver mitochondria
29. Studies on the stereo-specificity of mitochondrial oxidation of phytanic acid and of -hydroxyphytanic acid
30. Infantile Refsum's disease (phytanic acid storage disease): A variant of Zellweger's syndrome?
31. Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: Plasma changes and skin fibroblast phytanic acid oxidase
32. Phytanic acid must be activated to phytanoyl-CoA prior to its alpha-oxidation in rat liver peroxisomes
33. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors
34. Alpha-oxidation of 3-methyl-substituted fatty acids in rat liver. Production of formic acid instead of CO2, cofactor requirements, subcellular localization and formation of a 2-hydroxy-3-methylacyl-CoA intermediate
35. Phytanoyl-CoA hydroxylase is present in human liver, located in peroxisomes, and deficient in Zellweger syndrome: Direct, unequivocal evidence for the new, revised pathway of phytanic acid alpha-oxidation in humans
36. Formation of a 2-methyl-branched fatty aldehyde during peroxisomal alpha-oxidation
37. Resolution of the phytanic acid alpha-oxidation pathway: Identification of pristanal as product of the decarboxylation of 2-hydroxyphytanoyl-CoA
38. Phytanic acid alpha-oxidation: Identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its localisation in peroxisomes
39. Purification, molecular cloning, and expression of 2-hydroxyphytanoyl-CoA lyase, a peroxisomal thiamine pyrophosphate-dependent enzyme that catalyzes the carbon-carbon bond cleavage during alpha-oxidation of 3-methyl-branched fatty acids
40. Identification of pristanal dehydrogenase activity in peroxisomes: Conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes
41. Characteristics and subcellular localization of pristanoyl-CoA synthetase in rat liver
42. Human very-long-chain acyl-CoA synthetase: Cloning, topography, and relevance to branched-chain fatty acid metabolism
43. Phytanoyl-coenzyme A hydroxylase deficiency - The enzyme defect in Refsum's disease
44. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene
45. Identification of PAHX, a Refsum disease gene
46. Human phytanoyl-CoA hydroxylase: Resolution of the gene structure and the molecular basis of Refsum's disease
47. Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder
48. Phytanoyl-CoA hydroxylase is not only deficient in classical Refsum disease but also in rhizomelic chondrodysplasia punctata
49. Peroxisome biogenesis disorders: Genetics and cell biology
50. Peroxisomal disorders: Clinical, biochemical, and molecular aspects
51. Identification of genetic heterogeneity in Refsum's disease
52. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata
53. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor
54. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor
55. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy
56. 'Chemical co-substrate rescue' of phytanoyl-CoA 20hydroxylase mutants causing Refsum's Disease
57. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR
58. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
59. Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor alfa (PPARalfa) in sterol carrier protein 2-/sterol carrier protein x-deficient mice
60. Pristanic acid and phytanic acid. Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha
61. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function